1.
Borkar N, Gote S, Salvi P, Khobragade K. Physicians’ perspectives on irritable bowel syndrome, diagnosis and management in India: insights from in-clinic questionnaire-based survey study with a focus on Rifaximin. Int J Community Med Public Health [Internet]. 2025 Oct. 31 [cited 2025 Nov. 13];12(11):5138-42. Available from: https://www.ijcmph.com/index.php/ijcmph/article/view/14737